Working… Menu

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03088540
Recruitment Status : Active, not recruiting
First Posted : March 23, 2017
Last Update Posted : August 17, 2021
Information provided by (Responsible Party):
Regeneron Pharmaceuticals